EGFR, as an upstream key regulatory molecule of the two signaling pathways of PI3K/AKT and MEK/ERK, plays a critical role in carcinogenesis in GBM occurrence and progression [33, 34]. This evidence concerns the gene AKT1 and glioblastoma.